Capital Fund Management (CFM)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Sell
50,800
-39,800
-44% -$14.2M 0.08% 346
2025
Q4
$29.7M Sell
90,600
-57,700
-39% -$18.3M 0.08% 329
2025
Q3
$41.9M Buy
148,300
+1,600
+1% +$464K 0.11% 237
2025
Q2
$41M Sell
146,700
-157,800
-52% -$44.7M 0.11% 252
2025
Q1
$94.9M Buy
304,500
+190,100
+166% +$56.1M 0.27% 72
2024
Q4
$29.8M Sell
114,400
-94,800
-45% -$28.1M 0.08% 356
2024
Q3
$67.4M Sell
209,200
-83,500
-29% -$27.3M 0.18% 150
2024
Q2
$91.5M Sell
292,700
-46,600
-14% -$13.7M 0.27% 90
2024
Q1
$96.5M Buy
339,300
+125,200
+58% +$36.6M 0.28% 72
2023
Q4
$61.7M Buy
214,100
+4,800
+2% +$1.31M 0.17% 146
2023
Q3
$56.3M Sell
209,300
-40,800
-16% -$10.2M 0.19% 130
2023
Q2
$55.5M Buy
250,100
+117,500
+89% +$27.3M 0.23% 108
2023
Q1
$32.1M Buy
132,600
+117,700
+790% +$28.9M 0.15% 174
2022
Q4
$3.91M Sell
14,900
-14,700
-50% -$3.94M 0.03% 705
2022
Q3
$6.67M Sell
29,600
-500
-2% -$121K 0.05% 452
2022
Q2
$7.32M Buy
+30,100
New +$7.38M 0.07% 406
2022
Q1
Sell
-20,500
Closed -$4.61M 1425
2021
Q4
$4.61M Buy
20,500
+3,900
+23% +$823K 0.03% 672
2021
Q3
$3.53M Buy
+16,600
New +$3.82M 0.03% 714
2021
Q1
Sell
-91,500
Closed -$21M 1251
2020
Q4
$21M Sell
91,500
-46,000
-33% -$10.6M 0.2% 125
2020
Q3
$34.9M Sell
137,500
-28,100
-17% -$6.96M 0.43% 43
2020
Q2
$39.1M Sell
165,600
-134,900
-45% -$30.8M 0.62% 18
2020
Q1
$60.9M Buy
300,500
+113,000
+60% +$24.7M 0.94% 7
2019
Q4
$45.2M Buy
187,500
+177,800
+1,833% +$39.2M 0.36% 65
2019
Q3
$1.88M Buy
+9,700
New +$1.86M 0.02% 815
2018
Q4
Sell
-37,600
Closed -$7.79M 1817
2018
Q3
$7.79M Buy
37,600
+36,100
+2,407% +$7.11M 0.04% 586
2018
Q2
$277K Sell
1,500
-18,700
-93% -$3.31M ﹤0.01% 1813
2018
Q1
$3.44M Buy
20,200
+12,300
+156% +$2.26M 0.02% 815
2017
Q4
$1.37M Sell
7,900
-3,700
-32% -$655K 0.01% 1104
2017
Q3
$2.16M Buy
11,600
+2,200
+23% +$390K 0.02% 751
2017
Q2
$1.62M Sell
9,400
-16,500
-64% -$2.68M 0.01% 772
2017
Q1
$4.25M Sell
25,900
-5,400
-17% -$897K 0.04% 536
2016
Q4
$4.58M Sell
31,300
-51,400
-62% -$7.74M 0.04% 524
2016
Q3
$13.8M Buy
+82,700
New +$14M 0.13% 213
2016
Q2
Sell
-37,300
Closed -$5.59M 1497
2016
Q1
$5.59M Sell
37,300
-9,900
-21% -$1.47M 0.05% 400
2015
Q4
$7.66M Buy
47,200
+12,800
+37% +$2.01M 0.08% 331
2015
Q3
$4.76M Sell
34,400
-89,300
-72% -$14.1M 0.05% 411
2015
Q2
$19M Sell
123,700
-161,700
-57% -$25.9M 0.24% 108
2015
Q1
$45.6M Buy
285,400
+88,600
+45% +$14M 0.62% 21
2014
Q4
$31.3M Buy
196,800
+74,300
+61% +$11.6M 0.37% 54
2014
Q3
$17.2M Buy
122,500
+32,100
+36% +$4.19M 0.19% 128
2014
Q2
$10.7M Sell
90,400
-6,200
-6% -$718K 0.11% 216
2014
Q1
$11.9M Sell
96,600
-62,900
-39% -$7.63M 0.15% 161
2013
Q4
$18.2M Sell
159,500
-147,700
-48% -$16.8M 0.23% 75
2013
Q3
$34.4M Buy
307,200
+89,600
+41% +$9.72M 0.48% 30
2013
Q2
$21.5M Buy
+217,600
New +$22.6M 0.33% 41

Other funds holding AMGN

Capital Fund Management (CFM)'s AMGN Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Amgen (AMGN) stake by 75% in Q1 2026, selling an estimated $13.6M and leaving 12,941 shares worth $4.55M. The position accounts for 0.02% of the portfolio, ranked #937.

Capital Fund Management (CFM) first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $87.3M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital Fund Management (CFM) held 12,941 shares of Amgen worth $4.55M as of Q1 2026.
  • Capital Fund Management (CFM) sold 38,187 Amgen shares in Q1 2026, an estimated $13.6M.
  • Amgen made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #937 holding.
  • Capital Fund Management (CFM) first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
  • Capital Fund Management (CFM)'s Amgen position peaked at $87.3M in Q2 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.